How has been the historical performance of Aarti Drugs?

Answer:The historical performance of Aarti Drugs shows a fluctuating trend in key financial metrics over the years. Breakdown: Aarti Drugs' net sales have shown a decline from INR 2,716.05 crore in March 2023 to INR 2,387.03 crore in March 2025. This decline is mirrored in total operating income, which also decreased from INR 2,716.05 crore in March 2023 to INR 2,387.03 crore in March 2025. The total expenditure, excluding depreciation, decreased from INR 2,410.45 crore in March 2023 to INR 2,099.97 crore in March 2025, contributing to an operating profit (PBDIT) of INR 303.42 crore in March 2025, down from INR 307.79 crore in March 2023. Profit before tax followed a similar trend, decreasing from INR 224.18 crore in March 2023 to INR 211.77 crore in March 2025, while profit after tax slightly increased from INR 166.36 crore in March 2023 to INR 168.10 crore in March 2025. The company's total assets rose from INR 2,421.40 crore in March 2023 to INR 2,574.68 crore in March 2025, alongside total liabilities which increased from INR 2,421.40 crore to INR 2,574.68 crore in the same period. Cash flow from operating activities decreased from INR 358.00 crore in March 2024 to INR 244.00 crore in March 2025, indicating a tightening cash position. Overall, Aarti Drugs has experienced fluctuations in revenue and profit metrics, with a notable increase in total assets and liabilities over the years.